CALMARE THERAPEUTICS Inc

CALMARE THERAPEUTICS Inc remains a lean, research-driven entity whose precise industry classification is still evolving, yet it clearly orients around novel pain-management interventions and related therapeutic services designed for clinicians, hospital systems, and specialty pain centers seeking non-pharmacologic options. The firm’s emerging product suite combines digital and electrotherapy elements to position it alongside established medical-device frameworks within the broader SIC context for therapeutic and therapeutic equipment manufacturers, even as definitive filings that would cement that positioning are not yet available. Its target customers prioritize evidence-backed modalities and responsive service partnerships, creating demand for robust clinical data, regulatory transparency, and device reliability. Material risks include navigating the absence of a ticker, the uncertainty of the latest SEC filing, and the need to align any future approvals or reimbursement pathways with FDA and international medical-device standards, making regulatory compliance a critical focus. View live SEC filings on Earnings Feed.

Source: Earnings Feed research · last updated 11/24/2025